Cookies & Privacy

We use essential cookies to make our site work. With your permission, we’ll also use analytics and marketing cookies to improve your experience. You can change your choice anytime.

See our Privacy Policy for details.

Manage preferences
Back to Industry News
Medtech

Addlife Expands Labtech Division with Acquisition of Two Danish Companies

Summary generated with AI, editor-reviewed
Heartspace News Desk
Source: Medtech Magazine, Medtech Magazine
TL;DR

Addlife, through its Labtech business, acquired Danish companies Pharmacold A/S and Opitek International ApS, according to Medtech Magazine. Pharmacold, specializing in temperature-controlled storage, will be integrated into Addlife's Holm & Halby subsidiary to broaden their product portfolio and offerings. Addlife, a company known for strategic acquisitions, has further expanded its Labtech business area with the acquisition of Danish companies Pharmacold A/S and Opitek International ApS, according to Medtech Magazine. The acquisition of Pharmacold A/S, a specialist in temperature-controlled storage solutions for the pharmaceutical and healthcare industries, represents a key strategic.

Key takeaways

  • Addlife, a company known for strategic acquisitions, has further expanded its Labtech business area with the acquisition of Danish companies Pharmacold A/S and Opitek International ApS, according to Medtech Magazine
  • The acquisition of Pharmacold A/S, a specialist in temperature-controlled storage solutions for the pharmaceutical and healthcare industries, represents a key strategic move
  • Pharmacold will be integrated into Holm & Halby, a subsidiary within Addlife's Labtech division
Addlife, a company known for strategic acquisitions, has further expanded its Labtech business area with the acquisition of Danish companies Pharmacold A/S and Opitek International ApS, according to Medtech Magazine. The acquisition of Pharmacold A/S, a specialist in temperature-controlled storage solutions for the pharmaceutical and healthcare industries, represents a key strategic move. Pharmacold will be integrated into Holm & Halby, a subsidiary within Addlife's Labtech division. Mattias Bengtsson, Vice President of Biomedical and Research at Addlife, emphasized the benefits of the acquisition, stating, "The addition of Pharmacold, combined with Holm & Halby's Cold Storage division, allows us to offer a more comprehensive and extensive product portfolio." This integration is projected to enhance the range of available products and services for customers.

Related Topics

AddlifeacquisitionLabtechPharmacold A/SOpitek International ApS

Want coverage like this for your company?

Local & industry wins build trusted proof, SEO/geo signals and prime national editors.

Check fit (2 min)

Is this your company?

Set up real-time alerts and keep your Heartspace News coverage accurate. Verified teams can update profiles, request corrections, and collaborate on future stories.

Want to turn mentions into momentum? Find your best path with the Fit Checker. Verified profiles receive a free consult.

Set up alerts Takes under 1 minute • Free to claim

Share Your Thoughts

(0 comments)

Be the first to share your thoughts on this article!

Stay Updated

Create alertsRead original